Eurofins Scientific SE (EPA: ERF)
Market Cap | 9.88B |
Revenue (ttm) | 6.72B |
Net Income (ttm) | 325.90M |
Shares Out | 191.37M |
EPS (ttm) | 1.67 |
PE Ratio | 30.96 |
Forward PE | 14.92 |
Dividend | 0.50 (0.97%) |
Ex-Dividend Date | Jul 3, 2024 |
Volume | 909,343 |
Open | 51.08 |
Previous Close | 51.68 |
Day's Range | 51.06 - 52.18 |
52-Week Range | 39.47 - 62.10 |
Beta | 0.67 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Oct 18, 2024 |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, a... [Read more]
Financial Performance
Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/p/r/press9-2512897.jpg)
Eurofins Scientific announces the acquisition of Labormar, further expanding its presence in Latin America and its Food and Feed, Environmental, Cosmetic and Pharmacological testing offering in Colombia
BARRANQUILLA, Colombia--(BUSINESS WIRE)--The Eurofins network of companies, a world leader in food, environment, pharmaceutical and cosmetic product testing, announces the completion of the acquisitio...
![](https://cdn.snapi.dev/images/v1/m/a/biotech8-2492708.jpg)
Eurofins Scientific's stock drops on allegations from short-seller Muddy Waters
Eurofins Scientific shares plunged on Monday after Muddy Waters Research said in a report it had started shorting the laboratory-services company, alleging founder and Chief Executive Gilles Martin ha...
![](https://cdn.snapi.dev/images/v1/p/r/press8-2161737.jpg)
Eurofins Scientific Announces the Acquisition of Quasfar, Establishing a Presence in Colombia and Expanding the Presence of Eurofins Laboratories in Latin America
LUXEMBOURG--(BUSINESS WIRE)--The Eurofins network of companies, the global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced m...
![](https://cdn.snapi.dev/images/v1/p/r/press18-2161736.jpg)
Eurofins Scientific Announces the Acquisition of Labor 3, Further Expanding Its Offering to the Food and Feed Market in Brazil and the Presence of Eurofins Laboratories in Latin America
LUXEMBOURG--(BUSINESS WIRE)--The Eurofins network of companies, the global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced m...
![](https://cdn.snapi.dev/images/v1/p/r/press6-900633.jpg)
Eurofins and Rite Aid Launch an Over-the-Counter, FDA-Authorised, at-Home COVID-19 PCR Test in all Rite Aid Locations in the U.S.
LUXEMBOURG--(BUSINESS WIRE)--Eurofins (Paris:ERF), through its empowerDX subsidiary, and Rite Aid announce the launch of an over-the-counter, FDA-authorised[1], at-home COVID-19 PCR Test Kit. The co-b...
![](https://cdn.snapi.dev/images/v1/p/r/press2-897636.jpg)
TruGraf Contracted With Humana for In-network Coverage of Medicare Kidney Transplant Patients
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Transplant Genomics, Inc. (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide, is excited to announce...
![](https://cdn.snapi.dev/images/v1/p/r/press18-784915.jpg)
Eurofins Subsidiary empowerDX and Uber Team up, Offer At-home COVID-19 Testing Kits via On-demand Delivery in More Than Two Dozen U.S. Cities
LUXEMBOURG--(BUSINESS WIRE)--Eurofins subsidiary, empowerDX, is working with Uber to offer FDA-emergency use authorized, at-home COVID-19 testing kits to consumers.
![](https://cdn.snapi.dev/images/v1/i/m/im-263614width620size15005861664712778.jpg)
The Tell: Here are the top ‘high-conviction' buys for Q3 from star stock-pickers according to Morningstar
Research provider Morningstar is out with its list of the 10 most “high-conviction” purchases among “ultimate stock pickers,” and the results are a bit eclectic.